SPY403.41+1.69 0.42%
DIA325.16+2.93 0.91%
IXIC11,790.72-14.28 -0.12%

Axsome Therapeutics Q1 EPS $(1.03) Misses $(1.00) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(1.00) by 3 percent. This is a 32.05 percent decrease over losses of $(0.78) per share from

Benzinga · 05/02/2022 07:13
Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(1.00) by 3 percent. This is a 32.05 percent decrease over losses of $(0.78) per share from the same period last year.